R&D channel feed – Endpoints News

R&D channel feed

Akero exec calls FDA's accelerated approval guidance for MASH drugs 'bizarre'

3 months ago

Updated: Monte Rosa reports first data for molecular glue program licensed to Novartis

3 months ago

Cargo Therapeutics scraps R&D pipeline, axes bulk of workforce as it looks for an exit

3 months ago

Regenxbio shares new Duchenne gene therapy data ahead of big readout next year

3 months ago

Updated: Immunovant will not take rare disease drug to regulators despite Phase 3 win

3 months ago

Roche inks $1B+ biobucks deal with UK biotech for new antibody cancer targets

3 months ago

Servier pays $70M upfront for Black Diamond’s RAS- and RAF-targeted cancer drug

3 months ago

CRISPR company Arbor raises $73.9M to test therapy in clinical trials

3 months ago

AstraZeneca reports Phase 3 success for rare disease drug at heart of Amolyt deal

3 months ago

Incyte's stock sinks as pivotal skin disease data disappoint

3 months ago

Orca Bio's T cell therapy may help blood cancer patients avoid transplant issues

3 months ago

George Church spinout developing genomically recoded organisms cuts most employees

3 months ago

AstraZeneca spotlights first-in-human data for B7-H4-targeting ADC in endometrial cancer

3 months ago

Avidity seeks to 'set the standard' as it heads to FDA with Duchenne drug

3 months ago

Boston Pharma, building off MASH momentum, mulls an IPO ahead of Phase 3 trial

3 months ago

Pfizer terminates an early-stage STING agonist trial

3 months ago

Amgen reports more Uplizna data in myasthenia gravis ahead of FDA filing

3 months ago

#CROI25: Merck’s troubled HIV drug heads to regulators; ViiV seeks longer-acting HIV treatment

4 months ago

Ono licenses rare blood disease drug from Ionis for $280M upfront

4 months ago

Updated: Zealand partners with Roche on its amylin analog in a deal worth up to $5.3B

4 months ago

Gilead plans to skip from Phase 1 to Phase 3 with once-yearly HIV prevention drug

4 months ago

Arvinas, Pfizer’s PROTAC data fall short of hype in breast cancer

4 months ago

Beam shares promising first clinical data on gene editing treatment for a lung and liver disease

4 months ago

#AAD25: What you need to know from Amgen, Bristol Myers, J&J and more

4 months ago

First page Previous page 10 11 121314 15 16 Next page Last page